---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-24-001304"
form_type: "8-K"
ticker: null
cik: "0001621227"
company_name: "Adaptimmune Therapeutics PLC"
filed_at: "2024-02-16T23:59:59+00:00"
generated_at: "2026-06-06T00:14:38.041884+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Adaptimmune regains Nasdaq minimum bid price compliance; ADSs to remain listed

## Summary
- Received Nasdaq letter on Feb 16, 2024 confirming compliance with Listing Rule 5450(a)(1).
- Previously notified of non-compliance on Aug 31, 2023; ADSs closed below $1.00 for 30 consecutive days.
- Closing bid price exceeded $1.00 for ten consecutive trading days through Feb 15, 2024.
- Company now in full compliance with all Nasdaq listing standards; matter closed.

## SEC filing metadata
- accession: 0001558370-24-001304
- form_type: 8-K
- cik: 0001621227
- company_name: Adaptimmune Therapeutics PLC
- filed_at: 2024-02-16T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1621227/000155837024001304/0001558370-24-001304-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1621227/000155837024001304/adap-20240216x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-24-001304
- JSON: https://secwatch.observer/filing/0001558370-24-001304.json
- Plain text: https://secwatch.observer/filing/0001558370-24-001304.txt

## Key facts
- Listing & Compliance Notices
  Adaptimmune Therapeutics PLC received a nasdaq compliance regained notice regarding minimum bid price (rules 5450(a)(1)).
  - Exchange: nasdaq
  - Notice: compliance regained
  - Deficiency: minimum bid price
  - Rules: 5450(a)(1)
  source text: February 16, 2024, Adaptimmune Therapeutics plc (the “Company”) received a letter from The Nasdaq Stock Market LLC (“Nasdaq”) informing the Company that it has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5450(a)(1) for continued listing on The Nasdaq Global Select Market. Consequently, the Company is now in compliance with all applicable listing standards, and it will continue to be listed on The Nasdaq Global Select Market. ​ The Company was previously notified by Nasdaq on August 31, 2023 that it was not in compliance with the minimum bid price requir
  evidence_url: https://www.sec.gov/Archives/edgar/data/1621227/000155837024001304/0001558370-24-001304-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.